Загрузка...
Bacille-Calmette-Guerin non-responders: how to manage
Intravesical immunotherapy with bacille-Calmette-Guerin (BCG) is indicated in the treatment of high-risk and intermediate-risk non-muscle invasive bladder cancer (NMIBC). Our goal is to describe the various disease states following induction and maintenance BCG and to describe contemporary treatment...
Сохранить в:
| Опубликовано в: : | Transl Androl Urol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4708234/ https://ncbi.nlm.nih.gov/pubmed/26816828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2015.05.03 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|